This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Sleep Initiation and Maintenance Disorders
and you are
over 55
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

KI1001(Circadin®, Prolonged release tablet which contains melatonin) has showed its efficacy to improve sleep quality in over 55 years old primary insomnia patients. This is a bridging study to investigate the efficacy and safety of KI1001(Circadin®) in Korean patients.

Provided treatments

  • Drug: KI1001
  • Drug: Placebo KI1001

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01450228. The sponsor of the trial is Kuhnil Pharmaceutical Co., Ltd. and it is looking for 170 volunteers for the current phase.
Official trial title:
A Double-blind, Parallel Group, Randomised, Placebo Controlled, Multicenter, Bridging Phase III Study of Efficacy and Safety of KI1001 in the Improvement of Sleep Quality in ≥ 55 Years Old Insomnia Patients